Gene · 116
NIH grants1,702
NIH grants whose papers are about the gene, through NIH's grant-paper links.
381 to 400 of 1,702
Download this page as JSON| Grant | Title | ADCYAP1 papers | Newest fiscal year |
|---|---|---|---|
| F32DK124963 | Investigating sex-specific metabolic effects of disrupted selenocysteine lyase and selenocysteine tRNA in Agrp hypothalamic neurons | 1 | 2022 |
| I01BX004560 | CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer | 1 | 2022 |
| K01AG055694 | Receptor-mediated clearance of synaptic tau as a novel therapy for Alzheimer's disease. | 1 | 2022 |
| K01AG060040 | MOLECULAR MECHANISMS OF NATURAL LIFESPAN VARIATION | 1 | 2022 |
| K01HL136884 | Genetic and molecular basis of circadian rhythm disorders | 1 | 2022 |
| K01MH118428 | Neural Correlates of Location-Specific Contextual Threat Discrimination in Post-Traumatic Stress Disorders REV1 | 1 | 2022 |
| K01MH118467 | Characterizing the Neurobiology of Pathological Dissociation: Mechanisms of Face Perception and Self Referential Processing | 1 | 2022 |
| K08CA248723 | Assessment of Tim-4+ Pleural Macrophages as Negative Regulators of Anti-Tumor T Cell Immunity in Lung Cancer | 1 | 2022 |
| K23GM123320 | Administrative Supplement: Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome | 1 | 2022 |
| K24AR063120 | Outcomes Research in Rheumatic Diseases | 1 | 2022 |
| K99AA029467 | Neuropeptide-dependent parabrachial control of the BNST during alcohol abstinence-induced negative affect | 1 | 2022 |
| K99AG066849 | Exploring Common Biological Pathways Underlying Insulin Resistance and Alzheimer Disease using Genetic and Omic Tools | 1 | 2022 |
| K99AT010903 | Effects of light exposure on amygdala plasticity during adolescence: implications for anxiety and well-being | 1 | 2022 |
| P30DK079337 | UAB-UCSD O'Brien Center for Acute Kidney Injury Research | 1 | 2022 |
| P30ES006096 | Center for Environmental Genetics | 1 | 2022 |
| P30NS047101 | University of California San Diego Neuroscience Microscopy Imaging Core | 1 | 2022 |
| P41EB015922 | Laboratory of Neuro Imaging Resource (LONIR) | 1 | 2022 |
| P42ES010337 | Harnessing Technological Innovation and Community-Engaged Implementation Science to Optimize COVID-19 Testing for Women and Children in Underserved Communities | 1 | 2022 |
| P50CA062924 | SPORE in Gastrointestinal Cancers | 1 | 2022 |
| P50CA140388 | Administrative Supplement to MD Anderson Cancer Center Prostate Cancer SPORE | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/116/grants?page=20